• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrazolopyridines

5-Bromo-1H-pyrazolo[4,3-b]pyridine-3-carboxylic Acid: A Comprehensive Overview

5-Bromo-1H-pyrazolo[4,3-b]pyridine-3-carboxylic acid, identified by the CAS number 1884502-13-9, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of heterocyclic aromatic compounds, which are widely studied due to their unique electronic properties and potential applications in drug design. The structure of this molecule consists of a pyrazolo[4,3-b]pyridine ring system with a bromine substituent at the 5-position and a carboxylic acid group at the 3-position. These functional groups contribute to its chemical reactivity and biological activity.

The synthesis of 5-Bromo-1H-pyrazolo[4,3-b]pyridine-3-carboxylic acid typically involves multi-step organic reactions, including nucleophilic aromatic substitution and cyclization processes. Recent advancements in synthetic methodologies have enabled the efficient preparation of this compound with high purity. Researchers have also explored its structural analogs to understand the relationship between molecular structure and biological activity.

In terms of applications, 5-Bromo-1H-pyrazolo[4,3-b]pyridine-3-carboxylic acid has shown promise in various areas. For instance, studies have demonstrated its potential as a lead compound in the development of new pharmaceutical agents. Its ability to modulate specific biological targets makes it a valuable tool in drug discovery programs targeting diseases such as cancer and inflammatory disorders.

Recent research has focused on the pharmacokinetic properties of this compound. Studies conducted in preclinical models have revealed favorable absorption and distribution profiles, suggesting its potential suitability for systemic administration. Additionally, investigations into its metabolic pathways have provided insights into its stability and bioavailability.

The biological activity of 5-Bromo-1H-pyrazolo[4,3-b]pyridine-3-carboxylic acid is closely related to its ability to interact with key cellular proteins. Computational modeling techniques have been employed to predict binding affinities and optimize molecular interactions. These studies have highlighted the importance of the bromine substituent and carboxylic acid group in determining its bioactivity.

In conclusion, 5-Bromo-1H-pyrazolo[4,3-b]pyridine-3-carboxylic acid, with its unique structural features and promising biological properties, represents a valuable compound for further exploration in both academic and industrial settings. Ongoing research continues to uncover new insights into its potential applications, solidifying its position as an important molecule in contemporary chemical research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)